Targeting DDR2 for Treating Pancreatic Cancer.
Do CT, Pitta Venkata P, Prochnau JY, Singh D, Timilsina S, Subbarayalu P, Medina D, Abdulsahib S, Nirzhor S, Khan S, Li G, Polusani SR, Zhou D, Wang P, Chen Y, Vadlamudi RK, Hart MJ, Amaradhi R, McHardy SF, Rao MK.
Do CT, et al. Among authors: medina d.
Mol Cancer Ther. 2025 Jun 26. doi: 10.1158/1535-7163.MCT-24-1226. Online ahead of print.
Mol Cancer Ther. 2025.
PMID: 40568905